Catherine Ramsey Schulte
Stock Analyst at Robert W. Baird
(4.70)
# 781
Out of 5,005 analysts
574
Total ratings
52.9%
Success rate
11.6%
Average return
Main Sectors:
Stocks Rated by Catherine Ramsey Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Reiterated: Buy | $265 → $348 | $411.77 | -15.49% | 42 | Aug 7, 2026 | |
| TWST Twist Bioscience | Reiterated: Buy | $65 → $115 | $179.60 | -35.97% | 47 | Aug 4, 2026 | |
| CSTL Castle Biosciences | Reiterated: Buy | $43 → $36 | $35.93 | +0.19% | 47 | Jul 31, 2026 | |
| TEM Tempus AI | Reiterated: Buy | $59 | $85.08 | -30.65% | 4 | Jul 31, 2026 | |
| TECH Bio-Techne | Reiterated: Hold | $49 → $73 | $72.51 | +0.68% | 43 | Jun 26, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $155 → $156 | $175.21 | -10.96% | 44 | May 26, 2026 | |
| MTD Mettler-Toledo International | Reiterated: Hold | $1,445 → $1,194 | $1,545.26 | -22.73% | 28 | May 11, 2026 | |
| CAI Caris Life Sciences | Reiterated: Buy | $28 → $22 | $31.75 | -30.71% | 3 | May 8, 2026 | |
| GH Guardant Health | Reiterated: Buy | $120 → $129 | $177.33 | -27.25% | 2 | May 8, 2026 | |
| GRAL GRAIL | Reiterated: Buy | $82 → $70 | $132.63 | -47.22% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $363 → $387 | $442.94 | -12.63% | 44 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 → $117 | $151.02 | -22.53% | 43 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $53 → $43 | $45.01 | -4.47% | 14 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $653 → $639 | $678.60 | -5.84% | 56 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $249 → $245 | $227.33 | +7.77% | 30 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $3 | $7.63 | -60.68% | 23 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $11 | $15.29 | -28.06% | 28 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $109 → $137 | $271.90 | -49.61% | 54 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 8 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $102 | $87.85 | n/a | 1 | Mar 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $8 | $2.45 | n/a | 11 | Nov 2, 2018 |
Natera
Aug 7, 2026
Reiterated: Buy
Price Target: $265 → $348
Current: $411.77
Upside: -15.49%
Twist Bioscience
Aug 4, 2026
Reiterated: Buy
Price Target: $65 → $115
Current: $179.60
Upside: -35.97%
Castle Biosciences
Jul 31, 2026
Reiterated: Buy
Price Target: $43 → $36
Current: $35.93
Upside: +0.19%
Tempus AI
Jul 31, 2026
Reiterated: Buy
Price Target: $59
Current: $85.08
Upside: -30.65%
Bio-Techne
Jun 26, 2026
Reiterated: Hold
Price Target: $49 → $73
Current: $72.51
Upside: +0.68%
Agilent Technologies
May 26, 2026
Reiterated: Buy
Price Target: $155 → $156
Current: $175.21
Upside: -10.96%
Mettler-Toledo International
May 11, 2026
Reiterated: Hold
Price Target: $1,445 → $1,194
Current: $1,545.26
Upside: -22.73%
Caris Life Sciences
May 8, 2026
Reiterated: Buy
Price Target: $28 → $22
Current: $31.75
Upside: -30.71%
Guardant Health
May 8, 2026
Reiterated: Buy
Price Target: $120 → $129
Current: $177.33
Upside: -27.25%
GRAIL
May 6, 2026
Reiterated: Buy
Price Target: $82 → $70
Current: $132.63
Upside: -47.22%
May 6, 2026
Reiterated: Buy
Price Target: $363 → $387
Current: $442.94
Upside: -12.63%
May 4, 2026
Reiterated: Buy
Price Target: $129 → $117
Current: $151.02
Upside: -22.53%
Apr 29, 2026
Upgraded: Buy
Price Target: $53 → $43
Current: $45.01
Upside: -4.47%
Apr 24, 2026
Reiterated: Buy
Price Target: $653 → $639
Current: $678.60
Upside: -5.84%
Apr 22, 2026
Reiterated: Buy
Price Target: $249 → $245
Current: $227.33
Upside: +7.77%
Feb 26, 2026
Reiterated: Hold
Price Target: $2 → $3
Current: $7.63
Upside: -60.68%
Feb 12, 2026
Reiterated: Buy
Price Target: $17 → $11
Current: $15.29
Upside: -28.06%
Feb 6, 2026
Reiterated: Hold
Price Target: $109 → $137
Current: $271.90
Upside: -49.61%
Apr 18, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 4, 2019
Reiterated: Buy
Price Target: $102
Current: $87.85
Upside: n/a
Nov 2, 2018
Reiterated: Buy
Price Target: $9 → $8
Current: $2.45
Upside: n/a